| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptor, Insulin | 40 | 2014 | 847 | 2.060 |
Why?
|
| Salicylates | 16 | 2017 | 126 | 1.830 |
Why?
|
| Insulin Resistance | 25 | 2017 | 3864 | 1.670 |
Why?
|
| Phosphoproteins | 34 | 2008 | 2441 | 1.540 |
Why?
|
| Inflammation | 27 | 2017 | 10637 | 1.310 |
Why?
|
| NF-kappa B | 18 | 2020 | 2499 | 1.130 |
Why?
|
| Phosphotyrosine | 42 | 2008 | 457 | 1.110 |
Why?
|
| Phosphopeptides | 34 | 1998 | 241 | 1.060 |
Why?
|
| src Homology Domains | 22 | 2003 | 364 | 1.020 |
Why?
|
| Insulin | 48 | 2014 | 6582 | 0.760 |
Why?
|
| Tyrosine | 41 | 2003 | 1462 | 0.740 |
Why?
|
| Protein Structure, Secondary | 16 | 2014 | 1247 | 0.690 |
Why?
|
| Protein Tyrosine Phosphatases | 14 | 2000 | 473 | 0.690 |
Why?
|
| Amino Acid Sequence | 89 | 2009 | 13814 | 0.680 |
Why?
|
| Obesity | 23 | 2016 | 12746 | 0.650 |
Why?
|
| Diabetes Mellitus, Type 2 | 21 | 2017 | 11726 | 0.650 |
Why?
|
| Protein-Tyrosine Kinases | 28 | 2008 | 2455 | 0.640 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 13 | 2016 | 2282 | 0.620 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 13 | 2005 | 437 | 0.610 |
Why?
|
| Molecular Sequence Data | 88 | 2009 | 18111 | 0.610 |
Why?
|
| Phosphotransferases | 12 | 1993 | 308 | 0.580 |
Why?
|
| Phenylalanine | 9 | 2004 | 365 | 0.560 |
Why?
|
| I-kappa B Kinase | 11 | 2013 | 252 | 0.550 |
Why?
|
| Adipose Tissue | 11 | 2016 | 3280 | 0.540 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 11 | 1995 | 146 | 0.530 |
Why?
|
| Adaptor Proteins, Signal Transducing | 17 | 2014 | 2917 | 0.520 |
Why?
|
| Muscular Atrophy | 5 | 2017 | 347 | 0.470 |
Why?
|
| Models, Molecular | 26 | 2011 | 5451 | 0.470 |
Why?
|
| Protein Structure, Tertiary | 11 | 2014 | 3848 | 0.470 |
Why?
|
| Profilins | 1 | 2013 | 66 | 0.460 |
Why?
|
| Adipose Tissue, White | 2 | 2013 | 351 | 0.460 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 6 | 2004 | 315 | 0.430 |
Why?
|
| GTPase-Activating Proteins | 2 | 2017 | 498 | 0.420 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 15 | 2008 | 2916 | 0.420 |
Why?
|
| Signal Transduction | 43 | 2022 | 23404 | 0.410 |
Why?
|
| Haploinsufficiency | 1 | 2013 | 328 | 0.400 |
Why?
|
| Diabetes Complications | 2 | 2017 | 1359 | 0.390 |
Why?
|
| Glucose Transporter Type 4 | 2 | 2011 | 250 | 0.380 |
Why?
|
| Binding Sites | 41 | 2004 | 6111 | 0.380 |
Why?
|
| Lipodystrophy | 2 | 2009 | 147 | 0.370 |
Why?
|
| Blood Glucose | 15 | 2017 | 6254 | 0.370 |
Why?
|
| Sequence Homology, Amino Acid | 20 | 2003 | 2839 | 0.370 |
Why?
|
| Insulin Receptor Substrate Proteins | 20 | 2008 | 563 | 0.370 |
Why?
|
| Subcutaneous Fat | 1 | 2013 | 391 | 0.360 |
Why?
|
| Glucose Intolerance | 1 | 2013 | 577 | 0.340 |
Why?
|
| Phosphorylation | 41 | 2005 | 8436 | 0.330 |
Why?
|
| Animals | 107 | 2022 | 168768 | 0.330 |
Why?
|
| Enzyme Activation | 20 | 2009 | 3702 | 0.320 |
Why?
|
| Crystallography, X-Ray | 13 | 2011 | 2012 | 0.320 |
Why?
|
| Macrophages | 7 | 2016 | 5660 | 0.310 |
Why?
|
| Structure-Activity Relationship | 18 | 2011 | 3130 | 0.300 |
Why?
|
| Carrier Proteins | 6 | 2005 | 5023 | 0.290 |
Why?
|
| DNA-Binding Proteins | 9 | 2007 | 9647 | 0.290 |
Why?
|
| Cricetinae | 17 | 2014 | 2475 | 0.290 |
Why?
|
| CHO Cells | 14 | 2014 | 1409 | 0.290 |
Why?
|
| Oncogene Protein pp60(v-src) | 8 | 1995 | 77 | 0.290 |
Why?
|
| Protein Conformation | 25 | 2004 | 4010 | 0.280 |
Why?
|
| Mice | 54 | 2022 | 81201 | 0.280 |
Why?
|
| Hepatocytes | 3 | 2011 | 1211 | 0.280 |
Why?
|
| Proto-Oncogene Proteins | 14 | 2005 | 4554 | 0.270 |
Why?
|
| Protein Binding | 28 | 2009 | 9384 | 0.270 |
Why?
|
| Muscle, Skeletal | 8 | 2020 | 4925 | 0.260 |
Why?
|
| Mice, Obese | 7 | 2012 | 425 | 0.260 |
Why?
|
| Chloroquine | 1 | 2006 | 279 | 0.260 |
Why?
|
| Proinsulin | 7 | 1992 | 133 | 0.250 |
Why?
|
| Proteins | 18 | 2002 | 6100 | 0.250 |
Why?
|
| Sodium Salicylate | 2 | 2016 | 19 | 0.240 |
Why?
|
| Atherosclerosis | 3 | 2017 | 3444 | 0.240 |
Why?
|
| Transcription Factors | 9 | 2009 | 12207 | 0.240 |
Why?
|
| Receptors, Antigen, T-Cell | 8 | 1998 | 2540 | 0.230 |
Why?
|
| Homeostasis | 5 | 2013 | 3339 | 0.230 |
Why?
|
| Substrate Specificity | 15 | 1998 | 1802 | 0.220 |
Why?
|
| Hypoglycemic Agents | 4 | 2013 | 2873 | 0.220 |
Why?
|
| Glucose | 5 | 2017 | 4398 | 0.220 |
Why?
|
| Cachexia | 1 | 2004 | 205 | 0.220 |
Why?
|
| Thrombosis | 1 | 2017 | 2968 | 0.220 |
Why?
|
| Kinetics | 24 | 1995 | 6476 | 0.210 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 8 | 1998 | 180 | 0.210 |
Why?
|
| Dietary Fats | 4 | 2005 | 2016 | 0.210 |
Why?
|
| Nuclear Proteins | 5 | 2007 | 5856 | 0.210 |
Why?
|
| Recombinant Proteins | 21 | 2002 | 6621 | 0.200 |
Why?
|
| Phosphatidylinositol 3-Kinases | 26 | 2002 | 2938 | 0.200 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 3 | 2009 | 118 | 0.200 |
Why?
|
| Diaphragm | 2 | 2014 | 349 | 0.200 |
Why?
|
| Apolipoprotein E3 | 2 | 2011 | 97 | 0.190 |
Why?
|
| Mice, Transgenic | 11 | 2020 | 9735 | 0.190 |
Why?
|
| Muscle Development | 2 | 2020 | 271 | 0.190 |
Why?
|
| Iron-Binding Proteins | 1 | 2000 | 79 | 0.190 |
Why?
|
| Lipoproteins, VLDL | 2 | 2011 | 201 | 0.180 |
Why?
|
| Peptide Fragments | 12 | 1995 | 5096 | 0.180 |
Why?
|
| Peptides | 16 | 1998 | 4410 | 0.180 |
Why?
|
| Transfection | 13 | 2003 | 5895 | 0.180 |
Why?
|
| Interleukin-6 | 2 | 2007 | 3203 | 0.180 |
Why?
|
| Vasodilation | 2 | 2014 | 944 | 0.170 |
Why?
|
| Ligands | 4 | 2004 | 3282 | 0.170 |
Why?
|
| Humans | 121 | 2019 | 744366 | 0.170 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 8 | 2000 | 122 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 15 | 2020 | 21833 | 0.170 |
Why?
|
| Trypsin | 7 | 1995 | 511 | 0.170 |
Why?
|
| Mitochondria, Muscle | 1 | 2020 | 171 | 0.170 |
Why?
|
| Oligopeptides | 6 | 1995 | 1189 | 0.160 |
Why?
|
| Protein Kinases | 3 | 2005 | 1640 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 8 | 2000 | 234 | 0.160 |
Why?
|
| Affinity Labels | 3 | 1993 | 109 | 0.160 |
Why?
|
| Dimerization | 3 | 2005 | 895 | 0.160 |
Why?
|
| Rats | 21 | 2013 | 24252 | 0.160 |
Why?
|
| Glutathione Transferase | 9 | 1996 | 595 | 0.150 |
Why?
|
| Aspirin | 3 | 2011 | 3283 | 0.150 |
Why?
|
| Binding, Competitive | 9 | 1995 | 1157 | 0.150 |
Why?
|
| Circular Dichroism | 7 | 1994 | 354 | 0.150 |
Why?
|
| Glucose Tolerance Test | 6 | 2013 | 1151 | 0.150 |
Why?
|
| Recombinant Fusion Proteins | 22 | 2009 | 3773 | 0.150 |
Why?
|
| Cloning, Molecular | 9 | 2005 | 4320 | 0.150 |
Why?
|
| Mutation | 16 | 2014 | 29786 | 0.140 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2013 | 1115 | 0.140 |
Why?
|
| Cell Line | 19 | 2017 | 16000 | 0.140 |
Why?
|
| Maternal Behavior | 1 | 2019 | 311 | 0.140 |
Why?
|
| 3T3 Cells | 10 | 2000 | 1101 | 0.140 |
Why?
|
| Myostatin | 1 | 2017 | 124 | 0.140 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2006 | 2850 | 0.140 |
Why?
|
| Retroviridae Proteins, Oncogenic | 4 | 1997 | 76 | 0.140 |
Why?
|
| Phagocytosis | 1 | 2022 | 1539 | 0.140 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2016 | 555 | 0.140 |
Why?
|
| SH2 Domain-Containing Protein Tyrosine Phosphatases | 6 | 2000 | 45 | 0.140 |
Why?
|
| Object Attachment | 1 | 2019 | 313 | 0.140 |
Why?
|
| Genes, src | 6 | 1995 | 52 | 0.130 |
Why?
|
| Macromolecular Substances | 10 | 1996 | 1454 | 0.130 |
Why?
|
| Type C Phospholipases | 5 | 1998 | 292 | 0.130 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2016 | 124 | 0.130 |
Why?
|
| Overweight | 2 | 2017 | 2371 | 0.130 |
Why?
|
| Triglycerides | 3 | 2013 | 2453 | 0.130 |
Why?
|
| Mutagenesis, Site-Directed | 8 | 2000 | 1723 | 0.130 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1995 | 156 | 0.130 |
Why?
|
| Two-Hybrid System Techniques | 3 | 2005 | 464 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2006 | 3464 | 0.130 |
Why?
|
| Antigens, Polyomavirus Transforming | 2 | 1992 | 261 | 0.130 |
Why?
|
| Hyperinsulinism | 4 | 2008 | 415 | 0.130 |
Why?
|
| Oxytocin | 1 | 2019 | 394 | 0.130 |
Why?
|
| Membrane Proteins | 4 | 2007 | 7882 | 0.120 |
Why?
|
| Endopeptidases | 3 | 1993 | 772 | 0.120 |
Why?
|
| Fatty Acids | 1 | 2002 | 1809 | 0.120 |
Why?
|
| Osteocalcin | 1 | 2015 | 273 | 0.120 |
Why?
|
| Enzyme Inhibitors | 5 | 2004 | 3799 | 0.120 |
Why?
|
| Alternative Splicing | 2 | 2014 | 1117 | 0.120 |
Why?
|
| Antigens, Differentiation | 2 | 2013 | 927 | 0.120 |
Why?
|
| Liver | 7 | 2011 | 7475 | 0.110 |
Why?
|
| Thiazolidinediones | 2 | 2013 | 476 | 0.110 |
Why?
|
| Mice, Knockout | 2 | 2019 | 14561 | 0.110 |
Why?
|
| Cricetulus | 2 | 2014 | 818 | 0.110 |
Why?
|
| Endotoxemia | 1 | 2014 | 207 | 0.110 |
Why?
|
| Insulinoma | 2 | 1992 | 124 | 0.110 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 1997 | 1660 | 0.110 |
Why?
|
| NIH 3T3 Cells | 1 | 2014 | 677 | 0.110 |
Why?
|
| Insulin Antibodies | 3 | 1993 | 31 | 0.110 |
Why?
|
| Somatostatin | 3 | 1983 | 459 | 0.100 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1994 | 431 | 0.100 |
Why?
|
| Sarcopenia | 1 | 2017 | 368 | 0.100 |
Why?
|
| Protein Multimerization | 1 | 2017 | 971 | 0.100 |
Why?
|
| Peptides, Cyclic | 1 | 1994 | 400 | 0.100 |
Why?
|
| Drug Design | 1 | 1997 | 1076 | 0.100 |
Why?
|
| Prediabetic State | 1 | 2017 | 499 | 0.100 |
Why?
|
| Cell Membrane | 6 | 1995 | 3749 | 0.100 |
Why?
|
| Apoptosis | 5 | 2022 | 9724 | 0.100 |
Why?
|
| Polyubiquitin | 1 | 2011 | 70 | 0.100 |
Why?
|
| Chromatography, High Pressure Liquid | 11 | 1993 | 1572 | 0.100 |
Why?
|
| Endothelium, Vascular | 2 | 2014 | 4459 | 0.100 |
Why?
|
| Diabetes Mellitus | 4 | 2009 | 5749 | 0.100 |
Why?
|
| Hypertriglyceridemia | 2 | 2011 | 293 | 0.100 |
Why?
|
| Muscle Proteins | 2 | 2012 | 1158 | 0.100 |
Why?
|
| Placebos | 3 | 2017 | 1676 | 0.100 |
Why?
|
| GRB2 Adaptor Protein | 8 | 1998 | 103 | 0.100 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2017 | 3255 | 0.100 |
Why?
|
| Molecular Weight | 9 | 1995 | 2255 | 0.100 |
Why?
|
| Bone Remodeling | 1 | 2015 | 575 | 0.100 |
Why?
|
| Serine | 3 | 2004 | 826 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 13 | 1996 | 3759 | 0.090 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2011 | 148 | 0.090 |
Why?
|
| Protein Structure, Quaternary | 2 | 2017 | 436 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 4 | 1995 | 1988 | 0.090 |
Why?
|
| Cytoplasmic Granules | 1 | 1992 | 610 | 0.090 |
Why?
|
| Up-Regulation | 4 | 2012 | 4222 | 0.090 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2011 | 262 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2012 | 1790 | 0.090 |
Why?
|
| Gene Expression | 6 | 2016 | 7798 | 0.090 |
Why?
|
| Endocytosis | 4 | 1997 | 985 | 0.090 |
Why?
|
| Retroviridae Proteins | 1 | 1989 | 98 | 0.090 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2009 | 137 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 1997 | 2126 | 0.090 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2011 | 246 | 0.090 |
Why?
|
| PPAR gamma | 1 | 2012 | 493 | 0.080 |
Why?
|
| Tissue Transplantation | 1 | 2009 | 130 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2012 | 3084 | 0.080 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 874 | 0.080 |
Why?
|
| Vanadates | 4 | 2003 | 82 | 0.080 |
Why?
|
| Cathepsins | 1 | 2010 | 241 | 0.080 |
Why?
|
| Double-Blind Method | 6 | 2017 | 12025 | 0.080 |
Why?
|
| T-Lymphocytes | 10 | 1997 | 10183 | 0.080 |
Why?
|
| Adipokines | 1 | 2011 | 320 | 0.080 |
Why?
|
| Blotting, Northern | 2 | 2003 | 1581 | 0.080 |
Why?
|
| Male | 37 | 2020 | 350115 | 0.080 |
Why?
|
| Calorimetry | 1 | 2008 | 126 | 0.080 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2013 | 745 | 0.080 |
Why?
|
| Ubiquitin | 2 | 2004 | 851 | 0.080 |
Why?
|
| Protein Precursors | 1 | 1992 | 1154 | 0.080 |
Why?
|
| Salicylic Acid | 2 | 2013 | 56 | 0.080 |
Why?
|
| Cell Hypoxia | 1 | 2011 | 675 | 0.080 |
Why?
|
| Clinical Trials as Topic | 3 | 2011 | 7914 | 0.080 |
Why?
|
| Prodrugs | 1 | 2010 | 268 | 0.080 |
Why?
|
| DNA, Complementary | 3 | 2003 | 2050 | 0.080 |
Why?
|
| Rats, Zucker | 2 | 2012 | 128 | 0.080 |
Why?
|
| Isoenzymes | 4 | 1998 | 1728 | 0.080 |
Why?
|
| Protein Engineering | 1 | 1991 | 538 | 0.080 |
Why?
|
| Base Sequence | 6 | 2002 | 12797 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2012 | 4424 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2012 | 2988 | 0.070 |
Why?
|
| Killer Cells, Natural | 1 | 2016 | 2133 | 0.070 |
Why?
|
| Interleukin-1 | 1 | 2011 | 1263 | 0.070 |
Why?
|
| Mutation, Missense | 3 | 2014 | 2566 | 0.070 |
Why?
|
| Sequence Alignment | 6 | 2009 | 2256 | 0.070 |
Why?
|
| Photochemistry | 3 | 1993 | 238 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 2 | 2003 | 27 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2012 | 9145 | 0.070 |
Why?
|
| Immunoglobulin Idiotypes | 1 | 1986 | 201 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2013 | 10943 | 0.070 |
Why?
|
| Radioimmunoassay | 7 | 1986 | 919 | 0.070 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2008 | 475 | 0.070 |
Why?
|
| Tissue Distribution | 2 | 2003 | 2327 | 0.070 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 892 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2012 | 2016 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 2 | 2003 | 94 | 0.070 |
Why?
|
| Membrane Glycoproteins | 3 | 1998 | 3771 | 0.070 |
Why?
|
| Thinness | 1 | 2009 | 480 | 0.070 |
Why?
|
| Protein Isoforms | 2 | 2014 | 1730 | 0.070 |
Why?
|
| Peptide Mapping | 3 | 1996 | 263 | 0.070 |
Why?
|
| Muscle Contraction | 2 | 2014 | 1235 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 2 | 2003 | 147 | 0.070 |
Why?
|
| Heat-Shock Proteins | 1 | 2009 | 822 | 0.070 |
Why?
|
| Aortic Diseases | 1 | 2011 | 743 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2012 | 1403 | 0.060 |
Why?
|
| RNA, Messenger | 7 | 2012 | 13035 | 0.060 |
Why?
|
| Cytokines | 4 | 2014 | 7323 | 0.060 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1986 | 349 | 0.060 |
Why?
|
| Shc Signaling Adaptor Proteins | 4 | 1997 | 46 | 0.060 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2006 | 338 | 0.060 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2016 | 1519 | 0.060 |
Why?
|
| Precipitin Tests | 2 | 2003 | 829 | 0.060 |
Why?
|
| Aging | 3 | 2020 | 8664 | 0.060 |
Why?
|
| STAT5 Transcription Factor | 1 | 2005 | 259 | 0.060 |
Why?
|
| Milk Proteins | 1 | 2005 | 169 | 0.060 |
Why?
|
| Models, Structural | 2 | 1995 | 361 | 0.060 |
Why?
|
| Receptors, Antigen, B-Cell | 3 | 1996 | 548 | 0.060 |
Why?
|
| Leukocytes | 1 | 2012 | 2045 | 0.060 |
Why?
|
| DNA Primers | 3 | 2002 | 2891 | 0.060 |
Why?
|
| Cardiovascular Diseases | 4 | 2017 | 15160 | 0.060 |
Why?
|
| Carbohydrate Metabolism | 1 | 2005 | 265 | 0.060 |
Why?
|
| X-Ray Diffraction | 2 | 2002 | 420 | 0.060 |
Why?
|
| Protein Folding | 2 | 2000 | 840 | 0.060 |
Why?
|
| Janus Kinase 2 | 2 | 2005 | 528 | 0.060 |
Why?
|
| Weight Loss | 2 | 2012 | 2625 | 0.060 |
Why?
|
| Diabetic Retinopathy | 1 | 2012 | 1210 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2004 | 286 | 0.060 |
Why?
|
| Adipocytes | 2 | 2010 | 1185 | 0.060 |
Why?
|
| Cell Transformation, Viral | 2 | 1995 | 567 | 0.060 |
Why?
|
| Fatty Liver | 1 | 2009 | 727 | 0.050 |
Why?
|
| POU Domain Factors | 1 | 2002 | 46 | 0.050 |
Why?
|
| Glycoproteins | 3 | 1998 | 2266 | 0.050 |
Why?
|
| Autoantibodies | 2 | 1993 | 2036 | 0.050 |
Why?
|
| Escherichia coli | 6 | 1998 | 4217 | 0.050 |
Why?
|
| Hindlimb | 1 | 2004 | 504 | 0.050 |
Why?
|
| Cells, Cultured | 11 | 2016 | 19233 | 0.050 |
Why?
|
| Annelida | 1 | 2002 | 7 | 0.050 |
Why?
|
| Lamins | 1 | 2002 | 36 | 0.050 |
Why?
|
| Hydrolysis | 2 | 1994 | 682 | 0.050 |
Why?
|
| Anura | 1 | 2002 | 86 | 0.050 |
Why?
|
| Female | 28 | 2019 | 380193 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 6 | 1998 | 6313 | 0.050 |
Why?
|
| Diptera | 1 | 2002 | 53 | 0.050 |
Why?
|
| Phenotype | 3 | 2012 | 16367 | 0.050 |
Why?
|
| GRB10 Adaptor Protein | 2 | 2002 | 22 | 0.050 |
Why?
|
| Trans-Activators | 2 | 2005 | 2926 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2014 | 1862 | 0.050 |
Why?
|
| Retina | 1 | 2012 | 2616 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2011 | 5181 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 3511 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2011 | 1887 | 0.050 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 2 | 1999 | 127 | 0.050 |
Why?
|
| Liver Neoplasms, Experimental | 2 | 1992 | 191 | 0.050 |
Why?
|
| Lamin Type A | 1 | 2002 | 190 | 0.050 |
Why?
|
| C-Peptide | 5 | 2013 | 419 | 0.050 |
Why?
|
| Leucine | 2 | 2003 | 560 | 0.050 |
Why?
|
| Phosphates | 3 | 1995 | 785 | 0.050 |
Why?
|
| Codon | 1 | 2002 | 611 | 0.050 |
Why?
|
| Phosphatidylserines | 1 | 2022 | 193 | 0.050 |
Why?
|
| Citrate (si)-Synthase | 1 | 2020 | 42 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 329 | 0.050 |
Why?
|
| Neoplasm Transplantation | 1 | 2004 | 2086 | 0.050 |
Why?
|
| Crystallography | 2 | 1998 | 111 | 0.050 |
Why?
|
| DNA | 4 | 2002 | 7294 | 0.050 |
Why?
|
| Pneumonia | 1 | 2012 | 2133 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 1986 | 1352 | 0.050 |
Why?
|
| Friedreich Ataxia | 1 | 2000 | 76 | 0.050 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2002 | 371 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2002 | 315 | 0.050 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 6 | 1995 | 91 | 0.050 |
Why?
|
| Phagocytes | 1 | 2022 | 297 | 0.040 |
Why?
|
| Cross-Linking Reagents | 2 | 1993 | 694 | 0.040 |
Why?
|
| Single-Blind Method | 2 | 2013 | 1590 | 0.040 |
Why?
|
| Muscular Dystrophies | 1 | 2002 | 393 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 2008 | 2259 | 0.040 |
Why?
|
| Temperature | 2 | 2017 | 2204 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 3 | 2013 | 5867 | 0.040 |
Why?
|
| Bariatric Surgery | 1 | 2009 | 952 | 0.040 |
Why?
|
| Organ Size | 1 | 2004 | 2251 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 1993 | 3338 | 0.040 |
Why?
|
| Hyperglycemia | 1 | 2008 | 1373 | 0.040 |
Why?
|
| Molecular Structure | 4 | 1996 | 1899 | 0.040 |
Why?
|
| Clathrin | 2 | 1998 | 267 | 0.040 |
Why?
|
| Repressor Proteins | 2 | 2002 | 3024 | 0.040 |
Why?
|
| Fishes | 1 | 2002 | 569 | 0.040 |
Why?
|
| Receptors, Oxytocin | 1 | 2019 | 66 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2000 | 378 | 0.040 |
Why?
|
| Lymphocyte Count | 2 | 2012 | 793 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2010 | 2897 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2011 | 3390 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1997 | 494 | 0.040 |
Why?
|
| Histones | 1 | 2008 | 2598 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2001 | 880 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 1994 | 1801 | 0.040 |
Why?
|
| Lysine | 2 | 2013 | 1007 | 0.040 |
Why?
|
| Lipids | 3 | 2010 | 3307 | 0.040 |
Why?
|
| Plasmids | 1 | 2003 | 2308 | 0.040 |
Why?
|
| Adaptor Protein Complex mu Subunits | 1 | 1997 | 20 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 871 | 0.040 |
Why?
|
| Adaptor Protein Complex 3 | 1 | 1997 | 17 | 0.040 |
Why?
|
| Adaptor Protein Complex 1 | 1 | 1997 | 22 | 0.040 |
Why?
|
| GRB7 Adaptor Protein | 1 | 1997 | 3 | 0.040 |
Why?
|
| Adaptor Protein Complex 2 | 1 | 1997 | 43 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2011 | 4479 | 0.040 |
Why?
|
| Adiponectin | 2 | 2013 | 1101 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2011 | 18034 | 0.040 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 3047 | 0.040 |
Why?
|
| Arginine | 3 | 2013 | 944 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 1997 | 6171 | 0.040 |
Why?
|
| Leptin | 3 | 2014 | 1600 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 1998 | 317 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 1284 | 0.040 |
Why?
|
| Protein Sorting Signals | 1 | 1997 | 281 | 0.030 |
Why?
|
| Muscles | 1 | 2001 | 1614 | 0.030 |
Why?
|
| Thermodynamics | 3 | 2009 | 594 | 0.030 |
Why?
|
| Carnitine | 1 | 2017 | 246 | 0.030 |
Why?
|
| Dynamins | 1 | 1997 | 152 | 0.030 |
Why?
|
| Ceramides | 1 | 2017 | 199 | 0.030 |
Why?
|
| Myoblasts | 1 | 2017 | 238 | 0.030 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1996 | 110 | 0.030 |
Why?
|
| Biotin | 2 | 1995 | 254 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2003 | 1525 | 0.030 |
Why?
|
| Xenopus laevis | 1 | 2000 | 957 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2012 | 1335 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 2 | 1992 | 5263 | 0.030 |
Why?
|
| Phospholipase C gamma | 4 | 1998 | 128 | 0.030 |
Why?
|
| Protein Stability | 1 | 2017 | 556 | 0.030 |
Why?
|
| Immunosorbent Techniques | 2 | 1992 | 184 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 4 | 1996 | 116 | 0.030 |
Why?
|
| Pancreas | 2 | 1997 | 1687 | 0.030 |
Why?
|
| Somatostatin-28 | 3 | 1983 | 6 | 0.030 |
Why?
|
| Gene Expression Regulation | 4 | 2017 | 12073 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 1996 | 245 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 1995 | 146 | 0.030 |
Why?
|
| Body Mass Index | 2 | 2010 | 12721 | 0.030 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1996 | 573 | 0.030 |
Why?
|
| B-Lymphocytes | 3 | 1997 | 4666 | 0.030 |
Why?
|
| Polyomavirus | 1 | 1995 | 249 | 0.030 |
Why?
|
| Second Messenger Systems | 1 | 1995 | 206 | 0.030 |
Why?
|
| Genetic Variation | 2 | 2002 | 6542 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2012 | 7721 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1995 | 402 | 0.030 |
Why?
|
| Pyruvaldehyde | 1 | 2013 | 21 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 1997 | 709 | 0.030 |
Why?
|
| Gene Library | 1 | 1997 | 1074 | 0.030 |
Why?
|
| Micelles | 1 | 1994 | 203 | 0.030 |
Why?
|
| Rats, Wistar | 2 | 2012 | 1892 | 0.030 |
Why?
|
| Disulfides | 1 | 1996 | 457 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4751 | 0.030 |
Why?
|
| Exercise | 2 | 2007 | 5615 | 0.030 |
Why?
|
| Methionine | 2 | 1996 | 590 | 0.030 |
Why?
|
| Body Weight | 1 | 2004 | 4671 | 0.030 |
Why?
|
| Streptozocin | 1 | 2013 | 196 | 0.030 |
Why?
|
| Histidine | 2 | 1991 | 313 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2001 | 2751 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 1997 | 508 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2020 | 1868 | 0.030 |
Why?
|
| Avidin | 1 | 1993 | 44 | 0.030 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1992 | 87 | 0.030 |
Why?
|
| Kidney | 2 | 2013 | 7184 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2016 | 346 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 2751 | 0.030 |
Why?
|
| Lymphocyte Activation | 4 | 1996 | 5524 | 0.030 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1993 | 220 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2012 | 105 | 0.030 |
Why?
|
| Deoxyguanosine | 1 | 2012 | 84 | 0.030 |
Why?
|
| Middle Aged | 12 | 2017 | 213390 | 0.030 |
Why?
|
| Aged | 10 | 2017 | 163288 | 0.030 |
Why?
|
| Iron | 1 | 2000 | 1774 | 0.030 |
Why?
|
| Growth Substances | 1 | 1994 | 784 | 0.030 |
Why?
|
| Time Factors | 4 | 2013 | 40075 | 0.030 |
Why?
|
| Apolipoprotein C-I | 1 | 2011 | 7 | 0.030 |
Why?
|
| Brain | 1 | 2019 | 26388 | 0.030 |
Why?
|
| Brachial Artery | 1 | 2013 | 369 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2014 | 758 | 0.030 |
Why?
|
| Mutagenesis | 2 | 1993 | 1264 | 0.030 |
Why?
|
| Adult | 14 | 2017 | 214052 | 0.030 |
Why?
|
| Enzymes, Immobilized | 1 | 1991 | 48 | 0.030 |
Why?
|
| I-kappa B Proteins | 1 | 2012 | 225 | 0.030 |
Why?
|
| Cholesterol, VLDL | 1 | 2011 | 65 | 0.020 |
Why?
|
| Dogs | 3 | 1993 | 3912 | 0.020 |
Why?
|
| Microsomes | 1 | 1991 | 257 | 0.020 |
Why?
|
| Antigens, CD | 3 | 1998 | 4026 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1992 | 2186 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 2 | 1995 | 1364 | 0.020 |
Why?
|
| Oncogenes | 2 | 1996 | 1265 | 0.020 |
Why?
|
| Thrombin | 1 | 1993 | 598 | 0.020 |
Why?
|
| Down-Regulation | 3 | 2011 | 3001 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2013 | 560 | 0.020 |
Why?
|
| Hybridomas | 3 | 1996 | 452 | 0.020 |
Why?
|
| Epididymis | 1 | 2012 | 227 | 0.020 |
Why?
|
| Multigene Family | 1 | 2013 | 1102 | 0.020 |
Why?
|
| Survival Rate | 1 | 2004 | 12788 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1993 | 2556 | 0.020 |
Why?
|
| Quebec | 1 | 2010 | 134 | 0.020 |
Why?
|
| Microinjections | 3 | 1996 | 327 | 0.020 |
Why?
|
| Amides | 1 | 1993 | 459 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 1525 | 0.020 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2010 | 87 | 0.020 |
Why?
|
| Methyltyrosines | 1 | 1989 | 7 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 2 | 2002 | 175 | 0.020 |
Why?
|
| Cell Count | 1 | 2013 | 1856 | 0.020 |
Why?
|
| Proline | 1 | 1991 | 458 | 0.020 |
Why?
|
| ras Proteins | 1 | 1995 | 1060 | 0.020 |
Why?
|
| Fibroblasts | 2 | 1997 | 4162 | 0.020 |
Why?
|
| Glycine | 1 | 1992 | 671 | 0.020 |
Why?
|
| DNA Mutational Analysis | 3 | 1994 | 4185 | 0.020 |
Why?
|
| Baculoviridae | 3 | 1994 | 118 | 0.020 |
Why?
|
| Risk Factors | 3 | 2017 | 72296 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 1996 | 1904 | 0.020 |
Why?
|
| Monosaccharide Transport Proteins | 2 | 2003 | 440 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 1991 | 576 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1996 | 1821 | 0.020 |
Why?
|
| Cystatin C | 1 | 2010 | 250 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 1995 | 1146 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 3617 | 0.020 |
Why?
|
| Oocytes | 1 | 1993 | 1188 | 0.020 |
Why?
|
| Diabetic Angiopathies | 1 | 2013 | 818 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 8300 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2017 | 63107 | 0.020 |
Why?
|
| Food | 2 | 1983 | 772 | 0.020 |
Why?
|
| Regeneration | 1 | 2016 | 1485 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 2428 | 0.020 |
Why?
|
| Oncogene Protein v-cbl | 2 | 1997 | 11 | 0.020 |
Why?
|
| Tinnitus | 1 | 2010 | 195 | 0.020 |
Why?
|
| Guanine Nucleotide Exchange Factors | 3 | 1996 | 581 | 0.020 |
Why?
|
| Caloric Restriction | 1 | 2010 | 302 | 0.020 |
Why?
|
| Immunoconjugates | 1 | 1995 | 901 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 15520 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 6486 | 0.020 |
Why?
|
| Tissue Extracts | 1 | 1986 | 135 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2019 | 3486 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 2 | 1996 | 119 | 0.020 |
Why?
|
| Albuminuria | 1 | 2010 | 681 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2011 | 1375 | 0.020 |
Why?
|
| Adenosine Triphosphate | 2 | 1989 | 2027 | 0.020 |
Why?
|
| Receptor, erbB-2 | 2 | 1993 | 2417 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2013 | 3914 | 0.020 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 2 | 1995 | 34 | 0.020 |
Why?
|
| Cattle | 3 | 1998 | 3922 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 9445 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3873 | 0.020 |
Why?
|
| Oncogene Protein v-crk | 2 | 1995 | 6 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 1438 | 0.020 |
Why?
|
| Paxillin | 2 | 1995 | 86 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3921 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 1613 | 0.020 |
Why?
|
| Italy | 1 | 2007 | 832 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2009 | 783 | 0.020 |
Why?
|
| Avian Sarcoma Viruses | 2 | 1994 | 84 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2007 | 675 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 2216 | 0.020 |
Why?
|
| Autophagy | 1 | 2012 | 1297 | 0.020 |
Why?
|
| Autoantigens | 1 | 2008 | 892 | 0.010 |
Why?
|
| Hydrogen Bonding | 2 | 1995 | 291 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 1997 | 4463 | 0.010 |
Why?
|
| Phosphatidylinositols | 2 | 1997 | 291 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1984 | 380 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2008 | 2008 | 0.010 |
Why?
|
| Korea | 1 | 2003 | 99 | 0.010 |
Why?
|
| Cell Separation | 1 | 2009 | 1751 | 0.010 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2003 | 62 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 6489 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2009 | 3130 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2013 | 5974 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2012 | 2108 | 0.010 |
Why?
|
| Models, Biological | 2 | 1997 | 9584 | 0.010 |
Why?
|
| Chick Embryo | 2 | 1995 | 982 | 0.010 |
Why?
|
| Dietary Carbohydrates | 1 | 2007 | 905 | 0.010 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 625 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2011 | 1888 | 0.010 |
Why?
|
| Physical Exertion | 1 | 2005 | 695 | 0.010 |
Why?
|
| Anisomycin | 1 | 2001 | 28 | 0.010 |
Why?
|
| Placenta | 1 | 1991 | 1699 | 0.010 |
Why?
|
| Homozygote | 1 | 2007 | 1787 | 0.010 |
Why?
|
| Young Adult | 3 | 2014 | 56429 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 697 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2007 | 1997 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2001 | 77 | 0.010 |
Why?
|
| Conserved Sequence | 2 | 1995 | 1202 | 0.010 |
Why?
|
| Adolescent | 4 | 2014 | 85779 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 2010 | 1170 | 0.010 |
Why?
|
| Chemical Phenomena | 2 | 1996 | 518 | 0.010 |
Why?
|
| Glucose Clamp Technique | 1 | 2001 | 266 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 3778 | 0.010 |
Why?
|
| Postmenopause | 1 | 2010 | 2460 | 0.010 |
Why?
|
| Exons | 1 | 2007 | 2439 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2008 | 1350 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2013 | 5984 | 0.010 |
Why?
|
| Cell Division | 2 | 2000 | 4569 | 0.010 |
Why?
|
| Ectoderm | 1 | 2000 | 137 | 0.010 |
Why?
|
| RNA | 1 | 2010 | 2749 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2002 | 880 | 0.010 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2000 | 185 | 0.010 |
Why?
|
| Receptor, IGF Type 2 | 1 | 1998 | 35 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2003 | 1793 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2000 | 625 | 0.010 |
Why?
|
| Transcription Factor AP-2 | 1 | 1998 | 82 | 0.010 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 1997 | 67 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 1995 | 1692 | 0.010 |
Why?
|
| Freezing | 1 | 1998 | 303 | 0.010 |
Why?
|
| Naphthalenesulfonates | 1 | 1997 | 15 | 0.010 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 1998 | 209 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-crk | 1 | 1996 | 13 | 0.010 |
Why?
|
| Chromatin | 1 | 2008 | 2933 | 0.010 |
Why?
|
| Sequence Tagged Sites | 1 | 1996 | 94 | 0.010 |
Why?
|
| Crk-Associated Substrate Protein | 1 | 1996 | 41 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2002 | 2421 | 0.010 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 1996 | 76 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2001 | 2274 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 1996 | 156 | 0.010 |
Why?
|
| Receptors, Interleukin-4 | 1 | 1996 | 65 | 0.010 |
Why?
|
| Leucine Zippers | 1 | 1996 | 117 | 0.010 |
Why?
|
| Fluorine | 1 | 1996 | 83 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 1997 | 743 | 0.010 |
Why?
|
| Malonates | 1 | 1995 | 42 | 0.010 |
Why?
|
| Enzyme Precursors | 1 | 1996 | 176 | 0.010 |
Why?
|
| COS Cells | 1 | 1998 | 1161 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 1986 | 1862 | 0.010 |
Why?
|
| Leukemia, B-Cell | 1 | 1996 | 86 | 0.010 |
Why?
|
| Alleles | 1 | 2007 | 6933 | 0.010 |
Why?
|
| Son of Sevenless Proteins | 1 | 1995 | 27 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1991 | 4253 | 0.010 |
Why?
|
| Pedigree | 1 | 2003 | 4642 | 0.010 |
Why?
|
| Age of Onset | 1 | 2002 | 3270 | 0.010 |
Why?
|
| Ions | 1 | 1996 | 265 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 1998 | 453 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2002 | 3587 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 1998 | 506 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2012 | 11486 | 0.010 |
Why?
|
| Alanine | 1 | 1997 | 572 | 0.010 |
Why?
|
| Spodoptera | 1 | 1994 | 153 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1997 | 688 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 4982 | 0.010 |
Why?
|
| Carboxypeptidases | 2 | 1985 | 176 | 0.010 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 1995 | 190 | 0.010 |
Why?
|
| Risk | 1 | 2007 | 9688 | 0.010 |
Why?
|
| Nitrogen Isotopes | 1 | 1994 | 84 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1995 | 256 | 0.010 |
Why?
|
| Oncogene Proteins v-abl | 1 | 1993 | 22 | 0.010 |
Why?
|
| Molecular Mimicry | 1 | 1995 | 201 | 0.010 |
Why?
|
| Leukemia, T-Cell | 1 | 1994 | 104 | 0.010 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 1995 | 200 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2002 | 2504 | 0.010 |
Why?
|
| Injections, Subcutaneous | 2 | 1985 | 667 | 0.010 |
Why?
|
| Insulin Infusion Systems | 2 | 1985 | 212 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1998 | 1950 | 0.010 |
Why?
|
| Boston | 1 | 2007 | 9312 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1998 | 1547 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 2000 | 878 | 0.010 |
Why?
|
| Moths | 1 | 1993 | 87 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1993 | 306 | 0.010 |
Why?
|
| Chromatography, Gel | 2 | 1985 | 668 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1995 | 898 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2009 | 10483 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1993 | 223 | 0.010 |
Why?
|
| Biological Transport | 1 | 1998 | 2120 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 1986 | 2535 | 0.010 |
Why?
|
| Inositol Phosphates | 1 | 1993 | 180 | 0.010 |
Why?
|
| Glycogen | 1 | 1993 | 259 | 0.010 |
Why?
|
| Sequence Homology | 1 | 1993 | 203 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1994 | 708 | 0.010 |
Why?
|
| Catalysis | 1 | 1994 | 762 | 0.010 |
Why?
|
| Antibodies | 2 | 1993 | 2460 | 0.010 |
Why?
|
| Hypothalamus | 1 | 1998 | 1063 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 12952 | 0.010 |
Why?
|
| Computer Graphics | 1 | 1994 | 361 | 0.010 |
Why?
|
| Models, Chemical | 1 | 1994 | 626 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 1996 | 776 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 39052 | 0.010 |
Why?
|
| Coated Pits, Cell-Membrane | 1 | 1991 | 78 | 0.010 |
Why?
|
| Glutamates | 1 | 1993 | 398 | 0.010 |
Why?
|
| Xenopus | 1 | 1993 | 712 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 4328 | 0.010 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1993 | 362 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1995 | 970 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 1993 | 433 | 0.010 |
Why?
|
| Point Mutation | 1 | 1996 | 1624 | 0.010 |
Why?
|
| Polarography | 1 | 1989 | 10 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 1991 | 562 | 0.010 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1991 | 272 | 0.010 |
Why?
|
| Cytosol | 1 | 1993 | 901 | 0.010 |
Why?
|
| Pregnancy | 1 | 1991 | 29144 | 0.010 |
Why?
|
| Child | 2 | 2014 | 77709 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 1995 | 1423 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2002 | 3444 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1997 | 1917 | 0.010 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1988 | 104 | 0.010 |
Why?
|
| Annexins | 1 | 1988 | 38 | 0.010 |
Why?
|
| Phospholipids | 1 | 1992 | 784 | 0.000 |
Why?
|
| Zinc | 1 | 1992 | 684 | 0.000 |
Why?
|
| Cell Cycle | 1 | 1996 | 2967 | 0.000 |
Why?
|
| Glutamic Acid | 1 | 1993 | 1169 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2010 | 40559 | 0.000 |
Why?
|
| Child, Preschool | 2 | 1993 | 41005 | 0.000 |
Why?
|
| Mammals | 1 | 1992 | 1143 | 0.000 |
Why?
|
| Carboxypeptidases A | 1 | 1985 | 49 | 0.000 |
Why?
|
| Tosylphenylalanyl Chloromethyl Ketone | 1 | 1985 | 8 | 0.000 |
Why?
|
| Electrophoresis, Disc | 1 | 1985 | 70 | 0.000 |
Why?
|
| Manganese | 1 | 1988 | 408 | 0.000 |
Why?
|
| Sepharose | 1 | 1985 | 108 | 0.000 |
Why?
|
| Drosophila melanogaster | 1 | 1994 | 1708 | 0.000 |
Why?
|
| Ultraviolet Rays | 1 | 1989 | 1060 | 0.000 |
Why?
|
| Acetic Anhydrides | 1 | 1984 | 2 | 0.000 |
Why?
|
| Carboxypeptidase B | 1 | 1984 | 6 | 0.000 |
Why?
|
| Immune Sera | 1 | 1985 | 641 | 0.000 |
Why?
|
| Chemistry | 1 | 1984 | 352 | 0.000 |
Why?
|
| Chromatography, Affinity | 1 | 1985 | 549 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 2001 | 7182 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1994 | 4561 | 0.000 |
Why?
|
| Genetic Vectors | 1 | 1992 | 3424 | 0.000 |
Why?
|
| Dexamethasone | 1 | 1988 | 1951 | 0.000 |
Why?
|
| Databases, Factual | 1 | 1995 | 7730 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1996 | 9274 | 0.000 |
Why?
|
| Neurons | 1 | 1998 | 9340 | 0.000 |
Why?
|
| Fasting | 1 | 1983 | 1592 | 0.000 |
Why?
|
| Calcium | 1 | 1988 | 5755 | 0.000 |
Why?
|
| Swine | 1 | 1985 | 5918 | 0.000 |
Why?
|